Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate vs COC on Breast Cell Proliferation
NCT02922127Phase 1Completed
- Sponsor
- Columbia University
- Start
- Dec 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ulipristal in breast cancer (2 arms), sponsored by Columbia University. Primary endpoint: Change in breast epithelial cell proliferation rate at 3 months. Started Dec 2016; status: completed.
02
Drugs
ulipristal
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02922127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922127.